Corporate Personality Sanitization
Share
Martin Shkreli shares his perspective on how corporate culture suppresses authentic personalities, forcing people to conform to sanitized versions of themselves. He believes this leads to a less interesting and less honest business world.
Key Points:
-
Corporate Personality Suppression:
- When you enter corporate/pharma/finance, your personality gets "choked out"
- Your ability to express yourself freely ends
- Even basic freedoms like choosing what to wear to work are restricted
-
Impact on Business Leadership:
- CEOs become maximally uninteresting and inoffensive
- They can't have real personalities because someone will take issue
- Example: "Look at the average CEO of corporate America... I gotta say what is maximally the least interesting and least offensive"
-
Generational Impact:
- When speaking at Ivy League schools, students give standing ovations
- Students realize their personalities are about to be suppressed by corporate world
- Whether going into pharma or finance, "their life is over" regarding self-expression
-
Personal Philosophy:
- Refuses to conform to corporate personality expectations
- Believes showing who you are and having opinions shouldn't be held against you
- "If you spend the rest of your life trying to make somebody else happy and conforming to society, it's gonna be not a life worth living"
-
Cost of Authenticity:
- Acknowledges there's a price for maintaining authenticity
- Being yourself can lead to professional consequences
- Believes the trade-off is worth it to maintain personal identity
-
Modern Business Culture:
- Corporate world has become increasingly restrictive of authentic expression
- Having an opinion of any kind can be held against you
- System rewards those who suppress their true personalities
45:13 - 45:56
Full video: 01:42:17MS
Martin Shkreli
Former hedge fund manager and pharmaceutical executive. Founded Retrophin and Turing Pharmaceuticals, gaining notoriety for increasing the price of Daraprim.
Convicted of securities fraud in 2017, sentenced to seven years in federal prison. Banned from the pharmaceutical industry and ordered to return $64.6 million in profits.